Article
Germline mutations in the BRCA2 gene and susceptibility to hereditary prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Feb 2007
Agalliu Ilir, Kwon Erika M, Zadory Daniel, McIntosh Laura, Thompson Joseph, Stanford Janet L, Ostrander Elaine A
Abstract excerpt
PURPOSE: Several epidemiologic studies have reported that carriers of germline mutations in the BRCA2 gene have an increased risk of prostate cancer, with the highest risk observed in men diagnosed at earlier ages. However, studies of the contribution of BRCA2 mutations to the etiology of hereditary prostate cancer (HPC) have been inconsistent. EXPERIMENTAL DESIGN: To further address this issue, 266 subjects from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
